- Home
- PDX vs TLRY Comparison
PDX vs TLRY Comparison
Compare PDX & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PDX | TLRY |
|---|---|---|
| Founded | 2019 | N/A |
| Country | NY | Canada |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 920.1M | 688.9M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | PDX | TLRY |
|---|---|---|
| Price | $21.57 | $5.29 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $72.33 |
| AVG Volume (30 Days) | 106.8K | ★ 7.0M |
| Earning Date | 01-01-0001 | 04-01-2026 |
| Dividend Yield | ★ 4.95% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.79 |
| Revenue Next Year | N/A | $19.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.47 | $0.36 |
| 52 Week High | $25.25 | $15.70 |
Technical Indicators
Market Signals| Indicator | PDX | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 61.41 | 32.23 |
| Support Level | $21.50 | $1.12 |
| Resistance Level | $22.20 | $7.01 |
| Average True Range (ATR) | 0.32 | 0.25 |
| MACD | 0.05 | -0.07 |
| Stochastic Oscillator | 68.05 | 4.99 |
Price Performance
Historical ComparisonAbout PDX PIMCO Dynamic Income Strategy Fund of Beneficial Interest
PIMCO Dynamic Income Strategy Fund is a non-diversified, limited-term, closed-end management investment company. It seeks current income as a primary objective and capital appreciation as a secondary objective. The fund makes investments using a dynamic asset allocation plan among multiple sectors in the public and private credit markets globally, including corporate debt, mortgage-related and other asset-backed instruments, government and sovereign debt, taxable municipal bonds, and other fixed, variable, and floating-rate income-producing securities of U.S. and foreign issuers, including emerging market issuers and real estate-related investments.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.